Clinical Results of Selective Laser Trabeculoplasty.

Accession number;00A0359869
Title;Clinical Results of Selective Laser Trabeculoplasty.
Author; KAJIYA SHIRO (Univ. of Ryukyus, Fac. of Med.) HAYAKAWA KAZUHISA (Univ. of Ryukyus, Fac. of Med.) SAWAGUCHI SHOICHI (Univ. of Ryukyus, Fac. of Med.)
Journal Title;Journal of Japanese Ophthalmological Society
Journal Code:Z0666A
ISSN:0029-0203
VOL.104;NO.3;PAGE.160-164(2000)
Figure&Table&Reference;FIG.4, TBL.2, REF.14
Pub. Country;Japan
Language;Japanese
Abstract;Purpose: Selective laser trabeculoplasty (SLT) is a new technique aimed to developed to impact pigmented trabecular cells selectively. Compared with ordinary argon laser trabeculoplasty, it is expected to have fewer complications with more efficacy for open-angle glaucoma. In this study we performed SLT on 17 eyes of 10 patients with primary open-angle glaucoma and 1 eye with capsular glaucoma. Methods: Follow-up period was up to 10 months. Average energy irrachieted was 28.14 mJ (0.47 mJ*59 spots) against pigmented trabecular band over the half circumference of anterior chamber angle. Results: Preoperative mean intraocular pressure (IOP) was 22.8 mmHg and postoperative mean IOP was decreased significantly to 8.6, 17.3, and 16.1 mmHg at 1, 3, and 6 months after treatment, respectively. The average maximum IOP reduction was 8.8 (3-18) mmHg after SLT. Among 11 eyes showing transient IOP elevation, 6 eyes had an elevation of more than 5 mmHg. No remarkable postoperative complications were noted. Conclusion: SLT is a safe and effective modality for the treatment of open-angle glaucoma such as primary open-angle glaucoma (POAG) and capsular glaucoma. (author abst.)
FULLTEXT